high risk prostate cancer
Showing 1 - 7 of 7
Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,
Recruiting
- Neoadjuvant Therapy
- +3 more
- ADT
- +8 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022
High Risk Prostate Cancer Trial in Turku (Whole body contrast enhanced computer tomography, 99mTC-HMDP planar bone scintigraphy
Completed
- High Risk Prostate Cancer
- Whole body contrast enhanced computer tomography
- +4 more
-
Turku, FinlandDepartment of Urology
May 3, 2022
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
High Risk Prostate Cancer Trial in San Francisco (BKM120)
Terminated
- High Risk Prostate Cancer
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 7, 2021
Intermediate Risk Prostate Cancer, High Risk Prostate Cancer Trial in Brescia
Active, not recruiting
- Intermediate Risk Prostate Cancer
- High Risk Prostate Cancer
-
Brescia, ItalyUniversity and Spedali Civili - Brescia
Mar 16, 2020
HIGH RISK PROSTATE CANCER Trial in Toronto (Stereotactic Ablative Body Radiation (SBRT))
Unknown status
- HIGH RISK PROSTATE CANCER
- Stereotactic Ablative Body Radiation (SBRT)
-
Toronto, Ontairo, CanadaSunnybrook Health Sciences Center
Jan 20, 2020
High Risk Prostate Cancer Trial in Montreal (IMRT Technique)
Completed
- High Risk Prostate Cancer
- IMRT Technique
-
Montreal, Quebec, CanadaMcGill University Health Center
Sep 26, 2016